2.70
price up icon1.12%   0.03
after-market Dopo l'orario di chiusura: 2.70
loading
Precedente Chiudi:
$2.67
Aprire:
$2.65
Volume 24 ore:
44,771
Relative Volume:
0.12
Capitalizzazione di mercato:
$56.40M
Reddito:
-
Utile/perdita netta:
$-94.11M
Rapporto P/E:
-0.4493
EPS:
-6.01
Flusso di cassa netto:
$-86.06M
1 W Prestazione:
-2.17%
1M Prestazione:
+21.08%
6M Prestazione:
-40.13%
1 anno Prestazione:
-65.56%
Intervallo 1D:
Value
$2.63
$2.702
Intervallo di 1 settimana:
Value
$2.63
$2.9949
Portata 52W:
Value
$1.78
$8.58

Adverum Biotechnologies Inc Stock (ADVM) Company Profile

Name
Nome
Adverum Biotechnologies Inc
Name
Telefono
(650) 649-1004
Name
Indirizzo
100 CARDINAL WAY, REDWOOD CITY, CA
Name
Dipendente
155
Name
Cinguettio
@adverumbio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ADVM's Discussions on Twitter

Confronta ADVM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ADVM
Adverum Biotechnologies Inc
2.70 55.78M 0 -94.11M -86.06M -6.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-25 Iniziato Oppenheimer Outperform
2024-04-30 Iniziato H.C. Wainwright Buy
2022-07-07 Aggiornamento Truist Hold → Buy
2021-07-23 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-05-03 Downgrade SVB Leerink Outperform → Mkt Perform
2021-04-29 Downgrade Chardan Capital Markets Buy → Neutral
2021-04-29 Downgrade RBC Capital Mkts Outperform → Sector Perform
2021-04-29 Downgrade Truist Buy → Hold
2020-12-16 Iniziato UBS Neutral
2020-11-12 Aggiornamento Raymond James Underperform → Mkt Perform
2020-06-26 Downgrade Raymond James Mkt Perform → Underperform
2020-05-13 Iniziato RBC Capital Mkts Outperform
2020-05-05 Aggiornamento SunTrust Hold → Buy
2020-04-28 Iniziato Goldman Buy
2020-03-16 Iniziato SVB Leerink Outperform
2020-02-10 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2020-02-10 Aggiornamento Chardan Capital Markets Neutral → Buy
2019-10-15 Reiterato Chardan Capital Markets Neutral
2019-09-13 Reiterato Chardan Capital Markets Neutral
2019-06-14 Ripresa Raymond James Mkt Perform
2018-11-02 Downgrade Raymond James Outperform → Mkt Perform
2018-11-02 Downgrade SunTrust Buy → Hold
2018-09-21 Iniziato Cantor Fitzgerald Overweight
2018-08-30 Iniziato SunTrust Buy
2018-02-15 Ripresa Piper Jaffray Overweight
2017-10-12 Iniziato Raymond James Outperform
Mostra tutto

Adverum Biotechnologies Inc Borsa (ADVM) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about Adverum Biotechnologies Inc. stockTurbocharged investment results - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Adverum Biotechnologies Inc. a good long term investmentHigh-octane financial growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Adverum Biotechnologies Inc. Stock Analysis and ForecastMarket-leading capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Adverum Biotechnologies Inc. stock priceOutstanding stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream - GlobeNewswire Inc.

Jul 16, 2025
pulisher
Jul 16, 2025

How Adverum Biotechnologies Inc. stock performs during market volatilityFree Access to Investment Community - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

what makes adverum biotechnologies inc. stock price move sharplyDaily Volume Leaders - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Adverum Biotechnologies Inc. stock price move sharplyFree Access to Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Adverum Biotechnologies Inc. stock attracts strong analyst attentionProven High Yield Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Adverum Biotechnologies Up 22%, Insiders Still Down After US$526.8k Purchase - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Reversal Of Fortune For Adverum Biotechnologies Insiders Who Made A US$526.8k Purchase - Yahoo Finance

Jul 15, 2025
pulisher
Jun 30, 2025

Adverum Biotechnologies, Inc.(NasdaqCM: ADVM) dropped from Russell 3000 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 18, 2025

Adverum Biotechnologies shareholders approve stock option repricing - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Adverum Biotechnologies shareholders approve stock option repricing By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 13, 2025

Adverum Biotechnologies’ SWOT analysis: gene therapy stock faces pivotal year - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 06, 2025

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 06, 2025
pulisher
Jun 06, 2025

Adverum Biotechnologies (NASDAQ:ADVM) versus Metagenomi (NASDAQ:MGX) Head-To-Head Analysis - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Adverum Awards 14,610 Shares in Stock Options and RSUs to Key New Hires - Stock Titan

Jun 05, 2025
pulisher
May 16, 2025

Adverum Biotechnologies Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Sees Price Target Adjustment by RBC Capital | ADVM Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Receives Continued Buy Rating from Chardan Capital | ADVM Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Price Target Reduced by RBC Capit - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Rating Reiterated at 'Buy' by HC Wainwright | ADVM Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

RBC Cuts Price Target on Adverum Biotechnologies to $4 From $5, Keeps Sector Perform, Speculative Risk - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies: Q1 Earnings Snapshot - CT Insider

May 15, 2025
pulisher
May 14, 2025

Adverum (ADVM) Projects Funding Through Late 2025 | ADVM Stock N - GuruFocus

May 14, 2025

Adverum Biotechnologies Inc Azioni (ADVM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):